Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin.

Dvorakova K, Dorr RT, Valcic S, Timmermann B, Alberts DS.

Cancer Chemother Pharmacol. 1999;43(4):331-5.

PMID:
10071985
2.

Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.

Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y.

Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):53-8.

4.

Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 mice.

Stratton SP, Bangert JL, Alberts DS, Dorr RT.

Cancer Lett. 2000 Sep 29;158(1):47-52.

PMID:
10940508
5.

Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.

Lambert JD, Kim DH, Zheng R, Yang CS.

J Pharm Pharmacol. 2006 May;58(5):599-604.

PMID:
16640828
6.

Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, Dorr RT, Hara Y, Alberts DS.

Clin Cancer Res. 2003 Aug 15;9(9):3312-9.

8.
9.

Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization.

Bianchi A, Marchetti N, Scalia S.

J Pharm Biomed Anal. 2011 Dec 5;56(4):692-7. doi: 10.1016/j.jpba.2011.07.007. Epub 2011 Jul 14.

PMID:
21807473
10.

(-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.

Liao B, Ying H, Yu C, Fan Z, Zhang W, Shi J, Ying H, Ravichandran N, Xu Y, Yin J, Jiang Y, Du Q.

Int J Pharm. 2016 Oct 15;512(1):22-31. doi: 10.1016/j.ijpharm.2016.08.038. Epub 2016 Aug 18.

PMID:
27544847
11.

Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea.

Gensler HL, Timmermann BN, Valcic S, Wächter GA, Dorr R, Dvorakova K, Alberts DS.

Nutr Cancer. 1996;26(3):325-35.

PMID:
8910914
12.

Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue.

Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H.

Carcinogenesis. 1998 Oct;19(10):1771-6.

PMID:
9806157
13.
14.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41. Epub 2006 Mar 6.

PMID:
16519995
15.
16.

Skin penetration of epigallocatechin-3-gallate and quercetin from green tea and Ginkgo biloba extracts vehiculated in cosmetic formulations.

dal Belo SE, Gaspar LR, Maia Campos PM, Marty JP.

Skin Pharmacol Physiol. 2009;22(6):299-304. doi: 10.1159/000241299. Epub 2009 Sep 25.

PMID:
19786823
17.

Effects of polyphenols on skin damage due to ultraviolet A rays: an experimental study on rats.

Sevin A, Oztaş P, Senen D, Han U, Karaman C, Tarimci N, Kartal M, Erdoğan B.

J Eur Acad Dermatol Venereol. 2007 May;21(5):650-6.

PMID:
17447979
18.

Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins.

Hao X, Sun Y, Yang CS, Bose M, Lambert JD, Ju J, Lu G, Lee MJ, Park S, Husain A, Wang S.

Nutr Cancer. 2007;59(1):62-9.

PMID:
17927503
19.

Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention.

Proniuk S, Liederer BM, Blanchard J.

J Pharm Sci. 2002 Jan;91(1):111-6.

PMID:
11782902
20.

Cancer inhibition by green tea.

Fujiki H, Suganuma M, Okabe S, Sueoka N, Komori A, Sueoka E, Kozu T, Tada Y, Suga K, Imai K, Nakachi K.

Mutat Res. 1998 Jun 18;402(1-2):307-10.

PMID:
9675322

Supplemental Content

Support Center